John Washington

United States; California United States; Dublin California United States; Americas; North America; Northwest
Is it you?
Investor info
Type
Angel Investors / HNW
Stage focus
  • Seed Round
Industry focus
Description
Juhn Washington is a Board Member and serves as Vice President of Facilities and Human Resources at ImmunoScience. He was a very early major investor in ImmunoScience whose participation was key to the clinical trials in Sierra Leone. He had a keen interest in plastic technologies, which he studied at a technical school in Oakland, CA. He was employed by Kaiser Aerospace and then Applied Aerospace, initially as a technician before moving on to research and development responsibilities in the area of plastic composites. Both companies were heavily involved with government contracts for military equipment, communications satellites, military aircraft components and related products. Both companies were innovators in plastic and composite applications. Washington has been bringing this expertise to ImmunoScience's diagnostic product platform. After spending approximately 15 years in the plastics technology field, he acquired majority ownership of Carlel Cellular Partners. Carlel was an early participant in the cellular phone business. As the principal of this company, he was responsible for both day-to-day operations and strategic growth. Through his efforts, Carlel was sold in the early 90's for close to $20 million. After the sale, he temporarily retired. In 1995 he was introduced to ImmunoScience and invested in the Company. Since that time, he has worked as a consultant and as an innovative solver of various technical proble The most recent was a problem with a separation of the plastic components of the Salivax test kit wand. He analyzed the problem, determined a likely fix and sourced a company that was able to supply a high-pressure, high-frequency bonding machine that solved the problem.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Life Sciences
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.